Citigroup’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-100,800
Closed -$1.98M – 6267
2022
Q2
$1.98M Buy
+100,800
New +$2.11M ﹤0.01% 2108
2021
Q4
– Sell
-93,500
Closed -$2.44M – 6066
2021
Q3
$2.44M Buy
+93,500
New +$2.26M ﹤0.01% 2370

Other funds holding SHC

Citigroup's SHC Position: Q3 2026 in Review

Citigroup reduced its Sotera Health (SHC) stake by 49% in Q3 2026, selling an estimated $1.16M and leaving 65,842 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #3188.

Citigroup first reported a position in SHC in Q4 2020 and has held it in 24 quarters since. The position peaked at $2.29M in Q2 2026. 150 funds tracked by Wall St. Rank hold SHC as of Q3 2026.

  • Citigroup held 65,842 shares of Sotera Health worth $1.22M as of Q3 2026.
  • Citigroup sold 63,067 Sotera Health shares in Q3 2026, an estimated $1.16M.
  • Sotera Health made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #3188 holding.
  • Citigroup first reported a position in Sotera Health in Q4 2020 and has held it in 24 quarters since.
  • Citigroup's Sotera Health position peaked at $2.29M in Q2 2026.
  • 150 funds tracked by Wall St. Rank held Sotera Health as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.